NCT05714553 2025-07-18NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursNuCana plcPhase 1/2 Terminated19 enrolled
NCT02393248 2023-01-06Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)Incyte CorporationPhase 1/2 Terminated201 enrolled 71 charts
NCT00268918 2018-07-27Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer PatientsDana-Farber Cancer InstitutePhase 1 Completed24 enrolled